secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-04-03T23:59:59+00:00
Accession:  0001493152-24-012898
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity amends Series B Preferred Stock to remove voting rights; approved by holder
--------------------------------------------------------------------------------

- Amended Certificate of Designations removes voting rights of Series B Preferred Stock (non-voting except as required by law).
- Series B Preferred Stock: 600 shares designated at $10,000 stated value, cumulative 8% dividend (15% on Triggering Event).
- Initial conversion price $3.50; alternate conversion at 80% of lowest VWAP (70% if delisted/reverse split).
- Conversion capped at 4.99% beneficial ownership per holder and 19.9% of common stock absent shareholder approval.
- Holder of outstanding Series B Preferred Stock approved amendment via written consent on April 1, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224012898/0001493152-24-012898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224012898/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-012898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer